How many products are currently listed in the FDA Health Fraud/Tainted Products database for sexual enhancement?
Executive summary
The exact, up‑to‑the‑minute count of sexual‑enhancement products listed in the FDA’s Health Fraud/Tainted Products database cannot be established from the supplied reporting; available public analyses and FDA communications place the tally in the mid‑hundreds, with a rigorous 2007–2016 audit identifying 353 sexual‑enhancement entries and more recent agency language describing “more than 400” such tainted products [1] [2].
1. What the most rigorous retrospective audit found
A peer‑reviewed review of FDA warning data covering 2007–2016 compiled the agency’s Tainted Supplements dataset and—after removing duplicates and adding overlooked entries—reported 776 adulterated dietary supplement records overall, of which 353 (45.5%) were marketed for sexual enhancement; that study is the most detailed audited snapshot available in the reporting and quantifies undeclared prescription or other active drugs found in those 353 products [3] [1].
2. What the FDA and allied agencies say in public communications
FDA pages and public notifications repeatedly warn that sexual‑enhancement supplements are disproportionately found to contain hidden prescription drugs and that the agency’s published lists represent only a fraction of tainted products; in agency language and partner summaries the number of identified sexual‑enhancement products is described as “more than 400,” reflecting continued detections and ongoing enforcement beyond the 2007–2016 research window [4] [5] [2].
3. Why the exact “current” count is hard to pin down
The Health Fraud / Tainted Products listings evolve continuously: FDA posts individual public notifications, warning letters and recalls as they arise and explicitly notes the database covers only a portion of market activity, meaning a static number in secondary reporting will lag and different FDA pages or contractor audits may count entries differently (duplicates, date windows, or merged notices); the supplied sources therefore do not provide a single definitive current tally [5] [6] [7].
4. Reconciling the available figures
A conservative interpretation of the supplied reporting is this: the peer‑reviewed audit rooted in FDA data documents 353 distinct sexual‑enhancement tainted products in 2007–2016 [1], while more recent FDA/office summaries and partner sites assert the agency has identified over 400 such products in total, indicating growth in detections post‑2016 though the precise present‑day count is not published in the provided materials [2] [4].
5. What this means for readers and investigators
For policy analysts, clinicians and consumers the practical takeaway is that hundreds of sexual‑enhancement products have been confirmed as tainted and agency messaging emphasizes that absence from the list is not proof of safety; to obtain the live count one must query the FDA’s Health Fraud Product Database or the agency’s Sexual Enhancement notifications page directly, because the supplied reporting documents historic totals and qualitative warnings but does not include a definitive, real‑time numeric export of current listings [5] [4] [6].